6th Annual Winship Cancer Institute Gastrointestinal Cancer Symposium


7.00 AM Registration/breakfast/meet exhibitors

8.00 AM Welcome/opening remarks
Walter Curran, MD

Primary and Metastatic Hepatobiliary Malignancy

8.05 AM State-of-the-art management of hepatocellcular carcinoma (HCC)
Joseph F. Magliocca, MD, FACS

8.25 AM Adjuvant therapy for resected biliary malignancies:
Who could potentially benefit?
Walid Shaib, MD

8.45 AM Role of resection for non-colorectal, non- neuroendocrine tumor (NET) liver metastases
David Kooby, MD, FACS

9.05 AM Indications for catheter-based regional therapy for
malignant liver lesions: Yttrium-90 (Y90) or transarterial chemoembolization (TACE)?
Darren Kies, MD

9.25 AM Radiation therapy for malignant liver lesions: Is there a role?
Mark McDonald, MD

9.45 AM Case Discussion
Moderator: Shishir K. Maithel, MD
Panel: Joseph F. Magliocca, MD, FACS; Walid Shaib, MD; David Kooby, MD, FACS;
Darren Kies, MD; Mark McDonald, MD

10.15 AM BREAK (meet exhibitors)

Controversies in the Management of Colon and Rectal Cancer

10.30 AM Local excision of rectal cancer: Who, when, and how?
Patrick Sullivan, MD, FACS

10.50 AM Approach to the primary rectal tumor in patients with synchronous liver metastasis
Kenneth Cardona, MD, FACS

11.10 AM Locally-advanced rectal cancer: Is there a role for bimodality
therapy of chemo-radiotherapy only or chemotherapy and
Andrea Cercek, MD

11.40 AM New agents in advanced stage colorectal cancer: What is
their role?
Tanios Bekaii-Saab, MD

12.10 PM Case Discussion
Moderator: Bassel F. El-Rayes, MD
Panel: Patrick Sullivan, MD, FACS; Kenneth Cardona, MD, FACS; Andrea Cercek, MD;
Tanios Bekaii-Saab, MD; Jerome C. Landry, MD, MBA

12.30 PM LUNCH (meet exhibitors)

Advances in Pancreatic Cancer

1.10 PM Approach to borderline/locally-advanced pancreas cancer in the
era of FOLFIRINOX and gemcitabine/nab-paclitaxel
Bassel El-Rayes, MD

1.30 PM Beyond front-line therapy for metastatic pancreas cancer: What
are the options?
Olatunji Alese, MD

1.50 PM Endoscopic palliation of gastric and biliary obstruction in
advanced pancreas cancer
Field Willingham, MD, MPH

2.10 PM Conventional radiation vs stereotactic body radiation therapy (SBRT)
for pancreas cancer
Pretesh Patel, MD

2.30 PM Case Discussion
Moderator: Kenneth Cardona, MD, FACS
Panel: Maria C. Russell MD, FACS; Bassel El-Rayes, MD; Olatunji Alese, MD; Field Willingham, MD, MPH; Pretesh Patel, MD

3.00 PM Adjourn


Course Directors

Kenneth Cardona, MD, FACS
Assistant Professor of Surgery
Division of Surgical Oncology
Winship Cancer Institute of Emory University
Atlanta, Georgia

Field Willingham, MD, MPH
Assistant Professor of Medicine
Director of Endoscopy, Division of Digestive Diseases
Emory University School of Medicine
Atlanta, Georgia

Bassel F. El-Rayes, MD
Professor of Medical Oncology
Associate Director for Clinical Research
Director of Gastrointestinal Oncology Program
Winship Cancer Institute of Emory University
Atlanta, Georgia

Shishir K. Maithel, MD, FACS
Associate Professor of Surgery
Division of Surgical Oncology
Winship Cancer Institute of Emory University
Atlanta, Georgia

Visiting Faculty

Tanios Bekaii-Saab, MD
Associate Professor
The James Cancer Hospital
Ohio State University Comprehensive Cancer Center
Columbus, Ohio

Andrea Cercek, MD
Medical Oncologist Gastrointestinal Oncology Service
Memorial Sloan Kettering Cancer Center
New York, New York

Emory University Faculty

Olatunji Alese, MD
Assistant Professor
Department of Hematology and Medical Oncology

David Kooby, MD, FACS
Professor of Surgery
Director of Surgical Oncology, Emory/Saint
Joseph's Hospital
Director of Minimally Invasive GI Surgical Oncology

Joseph F. Magliocca, MD, FACS
Associate Professor of Surgery

Maria C. Russell, MD, FACS
Assistant Professor of Surgery
Division of Surgical Oncology

Patrick Sullivan, MD, FACS
Assistant Professor of Surgery
Division of Surgical Oncology

Darren Kies, MD
Assistant Professor
Division of Interventional Radiology
and Image Guided Medicine

Jerome C. Landry, MD, MBA
Professor of Radiation Oncology
Chief of Service, Edward Loughlin Oncology Center
Grady Memorial Hospital

Mark McDonald, MD
Associate Professor, Department of Radiation Oncology
Medical Director, Emory Proton Therapy Center

Pretesh Patel, MD
Assistant Professor
Department of Radiation Oncology

Walid L. Shaib, MD
Assistant Professor
Department of Hematology and Medical Oncology

Target Audience

This educational activity is specifically designed to meet the needs of practicing medical oncologists and other healthcare professionals involved in the treatment of patients with gastrointestinal (GI) malignancies.

Learning Objectives

After successful completion of this educational activity, participants should be able to:
  • Apply best practices in the management of patients with gastrointestinal (GI) malignancies, including integrating novel therapies when appropriate and individualizing patient care
  • Evaluate data for novel therapies for the treatment of GI malignancies and integrate these data into patient care
  • Integrate a multidisciplinary strategy to identify the most effective patient care approaches for patients with GI malignancies
  • Identify appropriate clinical trials for patients with GI malignancies


Disclosure of Relevant Financial Relationships

prIME Oncology assesses relevant financial relationships with its instructors, planners, managers, and other individuals who are in a position to control the content of CME activities. Any potential conflicts of interest that are identified are thoroughly vetted by prIME Oncology for fairness, balance, and scientific objectivity of data, as well as patient care recommendations. prIME Oncology is committed to providing its learners with high-quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial entity.

Disclosure Regarding Unlabeled Use

This activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration or European Medicines Agency. Please refer to the official prescribing information for each product discussed for discussions of approved indications, contraindications, and warnings.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Exhibitor Information

$1500 Exhibitor Package includes:

  • One draped 6’ table with (2) chairs
  • Registration and name badges for two (2) company representatives to exhibit and attend the educational session
  • Continental breakfast, breaks and lunch for two (2) company representatives
  • Post-meeting list of attendees (name, city, state)

Additional representatives may attend for $300 each.


The name and email addresses of both representatives attending are required fields. Payment can be made via credit card or by noting that you will send a check.

Checks should be made payable to:
Prime Oncology (Tax ID # 20-5392779)

Checks should be mailed to:
Attn: Amy Bugg
Two Concourse Parkway, Suite 260, Atlanta, GA 30328

Download Forms

Shipping to the Venue

If you are shipping materials to the hotel, please number each box in your shipment (eg, Box 1 of 3) and address packages as follows:

Your Name & Company’s Name
c/o Brittany Wesson
Intercontinental Buckhead Atlanta
3315 Peachtree Road NE, Atlanta, GA 30326
ATTN: Winship GI Cancer Symposium, November 7, 2015

For questions or further information, please contact
Amy Bugg Amy.Bugg@prIMEoncology.org or 678.942.0181


For additional information contact: Amy Bugg Amy.Bugg@prIMEoncology.org or 678.942.0181

Register Now
Register Now

Date And Location

Saturday, November 7, 2015
8.00 AM - 03.00 PM

InterContinental Buckhead Atlanta
3315 Peachtree Rd NE
Atlanta, Georgia

Registration Fees

$75 - Physician, PhD, PharmD
$25 - Mid-level and nurses
Complimentary for Fellows, Residents, Students, Lab Techs
$300 - Industry

A refund of your registration fee can be received if cancellation is requested by email no later than October 18, 2015.

The registration fee includes all scientific sessions, continuing education credit, electronic program materials, breakfast, refreshment breaks, lunch, and access to the exhibit area.


This activity is jointly provided by prIME Oncology and Winship Cancer Institute of Emory University.

prIME Oncology

Emory Winship

Continuing Education

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME®) through the joint providership of prIME Oncology and Winship Cancer Institute. prIME Oncology is accredited by the ACCME to provide continuing medical education for physicians.


prIME Oncology designates this live activity for a maximum of 6 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Several Options are available to organizations interested in supporting this conference. For more information, please contact Anne Rojas at Anne.Rojas@prIMEoncology.org

Continuing Education